Patrycja Przebieradło
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrycja Przebieradło has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Ruzik
Faculty of Medicine, Jan Kochanowski University in Kielce, Kielce, Poland
9 shared publications - Antonina Gaj-Hunter
Faculty of Medicine, Jan Kochanowski University in Kielce, Kielce, Poland
9 shared publications - Kaja Stolarska
Faculty of Medicine, Jan Kochanowski University in Kielce, Kielce, Poland
9 shared publications - Katarzyna Żurek
Faculty of Medicine, Jan Kochanowski University in Kielce, Kielce, Poland
9 shared publications - Monika Kowalska
Faculty of Medicine, Medical University of Lodz, Lodz, Poland
9 shared publications - Monika Rajs
Faculty of Medicine, University of Rzeszow, Rzeszow, Poland
9 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
OCULAR ADVERSE EFFECTS AND COMPLICATIONS ASSOCIATED WITH EYELASH EXTENSIONS: A NARRATIVE REVIEW
Eyelash extensions (EEs) have gained considerable popularity in recent years as a means of enhancing the aesthetics of the periocular region. Despite the cosmetic nature of the procedure, adverse effects involving the ocular surface have been reported in the literature. The aim of this study was to summarize the available evidence on complications associated with EEs. A narrative review of the literature was conducted using scientific publications identified through the PubMed database and Google Scholar, including articles published up to June 15, 2025. The search was performed using the following keywords and their combinations: eyelash extensions, eyelash extension complications, ocular surface, dry eye, blepharitis, corneal injury, keratitis, and ocular complications. Prospective and cross-sectional studies, as well as case reports, were included in the analysis. The studies reviewed reported both subjective ocular symptoms, such as irritation, tearing, and foreign body sensation, and objective ocular surface abnormalities, including reduced tear film break-up time (TBUT), meibomian gland dysfunction, and corneal epithelial damage. Case reports also suggest the possibility of rare but serious complications, including exposure keratopathy, chemical injury to the ocular surface, and bacterial keratitis. The findings highlight the importance of obtaining a history of eyelash extension (EE) use during ophthalmic assessment of patients presenting with symptoms of ocular surface disease. They also indicate the need to educate both individuals undergoing the procedure and those performing it about potential complications. However, the available evidence remains limited and heterogeneous, indicating the need for further prospective studies evaluating the safety of this procedure.
- 29 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessOCULAR ADVERSE EFFECTS AND COMPLICATIONS ASSOCIATED WITH EYELASH EXTENSIONS: A NARRATIVE REVIEW
Eyelash extensions (EEs) have gained considerable popularity in recent years as a means of enhancing the aesthetics of the periocular region. Despite the cosmetic nature of the procedure, adverse effects involving the ocular surface have been reported in the literature. The aim of this study was to summarize the available evidence on complications associated with EEs. A narrative review of the literature was conducted using scientific publications identified through the PubMed database and Google Scholar, including articles published up to June 15, 2025. The search was performed using the following keywords and their combinations: eyelash extensions, eyelash extension complications, ocular surface, dry eye, blepharitis, corneal injury, keratitis, and ocular complications. Prospective and cross-sectional studies, as well as case reports, were included in the analysis. The studies reviewed reported both subjective ocular symptoms, such as irritation, tearing, and foreign body sensation, and objective ocular surface abnormalities, including reduced tear film break-up time (TBUT), meibomian gland dysfunction, and corneal epithelial damage. Case reports also suggest the possibility of rare but serious complications, including exposure keratopathy, chemical injury to the ocular surface, and bacterial keratitis. The findings highlight the importance of obtaining a history of eyelash extension (EE) use during ophthalmic assessment of patients presenting with symptoms of ocular surface disease. They also indicate the need to educate both individuals undergoing the procedure and those performing it about potential complications. However, the available evidence remains limited and heterogeneous, indicating the need for further prospective studies evaluating the safety of this procedure.
- Open Access
- 25 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
MECHANISMS OF BACTERIAL MULTIDRUG RESISTANCE: FOCUS ON BIOCIDE-MEDIATED CROSS-RESISTANCE, GEOPOLITICAL DISSEMINATION, AND NOVEL THERAPEUTIC FRONTIERS
This article provides an in-depth review of the molecular mechanisms responsible for bacterial multidrug resistance (MDR), including efflux pump overexpression, enzymatic inactivation, target modification, and biofilm-associated tolerance. A structured literature search of major academic databases (PubMed, Google Scholar, and Cochrane Library) from 2010 to present was conducted to synthesize relevant molecular and clinical data. The paper analyzes epidemiological trends, the impact of geopolitical factors on MDR dissemination, and the growing burden on healthcare systems. It also evaluates current and emerging therapeutic strategies such as bacteriophage therapy, antimicrobial peptides, and efflux pump inhibitors, emphasizing translational barriers, regulatory limitations, and future research directions.
- 25 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessMECHANISMS OF BACTERIAL MULTIDRUG RESISTANCE: FOCUS ON BIOCIDE-MEDIATED CROSS-RESISTANCE, GEOPOLITICAL DISSEMINATION, AND NOVEL THERAPEUTIC FRONTIERS
This article provides an in-depth review of the molecular mechanisms responsible for bacterial multidrug resistance (MDR), including efflux pump overexpression, enzymatic inactivation, target modification, and biofilm-associated tolerance. A structured literature search of major academic databases (PubMed, Google Scholar, and Cochrane Library) from 2010 to present was conducted to synthesize relevant molecular and clinical data. The paper analyzes epidemiological trends, the impact of geopolitical factors on MDR dissemination, and the growing burden on healthcare systems. It also evaluates current and emerging therapeutic strategies such as bacteriophage therapy, antimicrobial peptides, and efflux pump inhibitors, emphasizing translational barriers, regulatory limitations, and future research directions.
- Open Access
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
MODERATE-INTENSITY PHYSICAL ACTIVITY IN PREGNANCY AS A STRATEGY FOR THE PREVENTION OF GESTATIONAL DIABETES MELLITUS: PATHOPHYSIOLOGIC RATIONALE AND CLINICAL EVIDENCE
Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy associated with significant short- and long-term consequences for both maternal and offspring health. Its development reflects progressive pregnancy-related insulin resistance driven by placental hormones and metabolic adaptations, which in some women is compounded by inadequate pancreatic β-cell compensation and inflammatory activation. Moderate-intensity physical activity has been proposed as a preventive strategy because it directly targets peripheral insulin sensitivity and glucose metabolism. This review examines the pathophysiologic rationale and clinical evidence supporting moderate-intensity exercise during pregnancy as an approach to reduce GDM risk. Mechanistic data demonstrate that exercise enhances insulin-independent glucose uptake through GLUT4 translocation, improves mitochondrial efficiency, reduces pro-inflammatory cytokines, favorably alters adipokine profiles, and limits excessive gestational weight gain. Observational studies consistently report inverse associations between maternal physical activity and GDM incidence. Randomized controlled trials show more variable findings but suggest modest reductions in risk, particularly when interventions are initiated early and adequately supervised. Meta-analyses indicate relative risk reductions of approximately 20-30%, although heterogeneity in study design and adherence remains substantial. Overall, moderate-intensity exercise represents a physiologically plausible, low-risk, and moderately effective strategy for GDM prevention and should be integrated into routine prenatal care.
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessMODERATE-INTENSITY PHYSICAL ACTIVITY IN PREGNANCY AS A STRATEGY FOR THE PREVENTION OF GESTATIONAL DIABETES MELLITUS: PATHOPHYSIOLOGIC RATIONALE AND CLINICAL EVIDENCE
Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy associated with significant short- and long-term consequences for both maternal and offspring health. Its development reflects progressive pregnancy-related insulin resistance driven by placental hormones and metabolic adaptations, which in some women is compounded by inadequate pancreatic β-cell compensation and inflammatory activation. Moderate-intensity physical activity has been proposed as a preventive strategy because it directly targets peripheral insulin sensitivity and glucose metabolism. This review examines the pathophysiologic rationale and clinical evidence supporting moderate-intensity exercise during pregnancy as an approach to reduce GDM risk. Mechanistic data demonstrate that exercise enhances insulin-independent glucose uptake through GLUT4 translocation, improves mitochondrial efficiency, reduces pro-inflammatory cytokines, favorably alters adipokine profiles, and limits excessive gestational weight gain. Observational studies consistently report inverse associations between maternal physical activity and GDM incidence. Randomized controlled trials show more variable findings but suggest modest reductions in risk, particularly when interventions are initiated early and adequately supervised. Meta-analyses indicate relative risk reductions of approximately 20-30%, although heterogeneity in study design and adherence remains substantial. Overall, moderate-intensity exercise represents a physiologically plausible, low-risk, and moderately effective strategy for GDM prevention and should be integrated into routine prenatal care.
- Open Access
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
LEAN PCOS AS A DISTINCT PHENOTYPE: METABOLIC DYSFUNCTION, DIAGNOSTIC IMPLICATIONS, AND THE EMERGING ROLE OF GLP-1–BASED THERAPIES
Background: Polycystic Ovary Syndrome (PCOS) affects 5–26% of reproductive-age women, yet current diagnostic frameworks insufficiently distinguish metabolically distinct phenotypes, particularly lean PCOS (BMI ≤25 kg/m²). Objective: This narrative review evaluates lean PCOS as a distinct pathophysiological entity and discusses its neuroendocrine and metabolic features, diagnostic challenges, and weight-stratified classification approaches. Methods: A literature search of PubMed, Google Scholar, and clinical guidelines (2015–2026) was conducted, including meta-analyses and comparative studies of lean and obese PCOS phenotypes. Results: Lean PCOS is characterized by neuroendocrine predominance (elevated LH/FSH ratio, adrenal androgen excess), intrinsic insulin resistance independent of BMI, and altered adipokine signaling reflecting adipose tissue dysfunction. Despite relatively favorable cardiometabolic profiles, patients exhibit subclinical hepatic and vascular risk. Genetic studies confirm distinct metabolic and insulin-signaling pathway involvement. Conclusions: Lean PCOS represents a biologically distinct phenotype requiring weight-stratified diagnostic strategies and phenotype-specific therapeutic approaches, including investigation of incretin-based therapies.
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessLEAN PCOS AS A DISTINCT PHENOTYPE: METABOLIC DYSFUNCTION, DIAGNOSTIC IMPLICATIONS, AND THE EMERGING ROLE OF GLP-1–BASED THERAPIES
Background: Polycystic Ovary Syndrome (PCOS) affects 5–26% of reproductive-age women, yet current diagnostic frameworks insufficiently distinguish metabolically distinct phenotypes, particularly lean PCOS (BMI ≤25 kg/m²). Objective: This narrative review evaluates lean PCOS as a distinct pathophysiological entity and discusses its neuroendocrine and metabolic features, diagnostic challenges, and weight-stratified classification approaches. Methods: A literature search of PubMed, Google Scholar, and clinical guidelines (2015–2026) was conducted, including meta-analyses and comparative studies of lean and obese PCOS phenotypes. Results: Lean PCOS is characterized by neuroendocrine predominance (elevated LH/FSH ratio, adrenal androgen excess), intrinsic insulin resistance independent of BMI, and altered adipokine signaling reflecting adipose tissue dysfunction. Despite relatively favorable cardiometabolic profiles, patients exhibit subclinical hepatic and vascular risk. Genetic studies confirm distinct metabolic and insulin-signaling pathway involvement. Conclusions: Lean PCOS represents a biologically distinct phenotype requiring weight-stratified diagnostic strategies and phenotype-specific therapeutic approaches, including investigation of incretin-based therapies.
- Open Access
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
MOGAD AS AN EMERGING CHALLENGE IN MODERN HEALTHCARE: FROM IMMUNOLOGY TO FUNCTIONAL RECOVERY
Background. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined autoimmune demyelinating disorder of the central nervous system, characterized by antibodies against myelin oligodendrocyte glycoprotein (MOG). Aim. The aim of this review is to systematize the most recent evidence regarding the MOGAD Material and Methods. A systematic literature review was conducted through a comprehensive search of databases (via the PubMed and Google Scholar platforms) Results. MOGAD may occur at any age, most frequently between 20 and 40 years, with variable epidemiological patterns. The clinical spectrum includes optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (ADEM), cortical encephalitis, and brainstem or cerebellar involvement. Age-related phenotypic differences are observed, with ADEM predominating in children and optic neuritis being more common in adults. Biomarkers such as serum MOG-IgG titers, cerebrospinal fluid (CSF) leukocytosis, and oligoclonal band status may reflect disease activity and help predict relapse risk. Persistent seropositivity is associated with a higher likelihood of recurrence, whereas transient positivity correlates with a more favorable course. Acute management primarily includes high-dose corticosteroids, intravenous immunoglobulins (IVIG), and plasma exchange (PLEX). Long-term treatment involves immunomodulatory or immunosuppressive therapies, with oral corticosteroids and IVIG demonstrating the best balance of efficacy and tolerability. Conclusions. MOGAD represents a distinct immunological entity with specific clinical, radiological, and serological features. Ongoing research continues to refine diagnostic criteria, biomarkers, and therapeutic strategies, improving disease recognition and management.
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessMOGAD AS AN EMERGING CHALLENGE IN MODERN HEALTHCARE: FROM IMMUNOLOGY TO FUNCTIONAL RECOVERY
Background. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined autoimmune demyelinating disorder of the central nervous system, characterized by antibodies against myelin oligodendrocyte glycoprotein (MOG). Aim. The aim of this review is to systematize the most recent evidence regarding the MOGAD Material and Methods. A systematic literature review was conducted through a comprehensive search of databases (via the PubMed and Google Scholar platforms) Results. MOGAD may occur at any age, most frequently between 20 and 40 years, with variable epidemiological patterns. The clinical spectrum includes optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (ADEM), cortical encephalitis, and brainstem or cerebellar involvement. Age-related phenotypic differences are observed, with ADEM predominating in children and optic neuritis being more common in adults. Biomarkers such as serum MOG-IgG titers, cerebrospinal fluid (CSF) leukocytosis, and oligoclonal band status may reflect disease activity and help predict relapse risk. Persistent seropositivity is associated with a higher likelihood of recurrence, whereas transient positivity correlates with a more favorable course. Acute management primarily includes high-dose corticosteroids, intravenous immunoglobulins (IVIG), and plasma exchange (PLEX). Long-term treatment involves immunomodulatory or immunosuppressive therapies, with oral corticosteroids and IVIG demonstrating the best balance of efficacy and tolerability. Conclusions. MOGAD represents a distinct immunological entity with specific clinical, radiological, and serological features. Ongoing research continues to refine diagnostic criteria, biomarkers, and therapeutic strategies, improving disease recognition and management.
- Open Access
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
THE SYNDROME OF CONSTANT HUNGER
Prader–Willi syndrome (PWS) is a rare genetic disorder resulting from abnormalities in gene expression. The inability to experience satiety constitutes the major challenge faced by individuals affected by this condition. This lifelong disturbance manifests through numerous complications, including morbid obesity, hypogonadism, infertility, diabetes mellitus, hypercholesterolemia, arterial hypertension, cardiovascular diseases, obstructive sleep apnoea, degenerative joint disease, immobility and even social stigmatization due to excessive body weight. The disease and its secondary complications significantly impair the quality of life and contribute to a reduced life expectancy. Although Prader–Willi syndrome is an uncommon clinical entity, the severity and complexity of its manifestations require continuous and coordinated efforts from physicians and healthcare professionals.
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessTHE SYNDROME OF CONSTANT HUNGER
Prader–Willi syndrome (PWS) is a rare genetic disorder resulting from abnormalities in gene expression. The inability to experience satiety constitutes the major challenge faced by individuals affected by this condition. This lifelong disturbance manifests through numerous complications, including morbid obesity, hypogonadism, infertility, diabetes mellitus, hypercholesterolemia, arterial hypertension, cardiovascular diseases, obstructive sleep apnoea, degenerative joint disease, immobility and even social stigmatization due to excessive body weight. The disease and its secondary complications significantly impair the quality of life and contribute to a reduced life expectancy. Although Prader–Willi syndrome is an uncommon clinical entity, the severity and complexity of its manifestations require continuous and coordinated efforts from physicians and healthcare professionals.
- Open Access
- 15 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
INNOVATIVE LASER TECHNOLOGIES IN THE TREATMENT OF ACNE AND POST-ACNE SCAR: A SYSTEMATIC REVIEW
Introduction and Objective: Aesthetic medicine is a rapidly developing field of medicine that significantly improves patients' quality of life in terms of self-esteem and psychological well-being. Modern laser technologies are not only used for rejuvenation, regeneration, or skin pigmentation removal procedures. Laser treatments play a crucial role in the treatment of acne and post-acne changes, allowing not only to reduce disease symptoms but also to minimize the risk of recurrence. The aim of this article is to analyze the course and effectiveness of acne and skin scar therapy through the use of laser technologies, as well as the complexity of potential benefits and possible limitations of their risks. Materials and Methods: This work is based on an analysis of scientific literature concerning the use of laser therapy in the treatment of acne and post-acne scars. A review of existing bibliography was conducted regarding individual types of laser therapy in relation to post-acne scars and acne dermatosis. The course and effectiveness of therapy using lasers were analyzed. Results: Literature analysis showed that modern laser technologies provide effective and relatively safe options for treating acne and post-acne scars. Laser therapy yields moderate but clinically relevant improvements in inflammatory lesions, post-acne scarring, and overall skin texture, with minimal risk when appropriate patient selection and operator expertise are ensured. Conclusions: Laser therapy can substantially enhance outcomes in acne and post-acne scar treatment and contribute to improved patient quality of life. Further studies are needed to establish optimal treatment protocols and to compare the effectiveness of specific laser types across different clinical forms of acne.
- 15 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessINNOVATIVE LASER TECHNOLOGIES IN THE TREATMENT OF ACNE AND POST-ACNE SCAR: A SYSTEMATIC REVIEW
Introduction and Objective: Aesthetic medicine is a rapidly developing field of medicine that significantly improves patients' quality of life in terms of self-esteem and psychological well-being. Modern laser technologies are not only used for rejuvenation, regeneration, or skin pigmentation removal procedures. Laser treatments play a crucial role in the treatment of acne and post-acne changes, allowing not only to reduce disease symptoms but also to minimize the risk of recurrence. The aim of this article is to analyze the course and effectiveness of acne and skin scar therapy through the use of laser technologies, as well as the complexity of potential benefits and possible limitations of their risks. Materials and Methods: This work is based on an analysis of scientific literature concerning the use of laser therapy in the treatment of acne and post-acne scars. A review of existing bibliography was conducted regarding individual types of laser therapy in relation to post-acne scars and acne dermatosis. The course and effectiveness of therapy using lasers were analyzed. Results: Literature analysis showed that modern laser technologies provide effective and relatively safe options for treating acne and post-acne scars. Laser therapy yields moderate but clinically relevant improvements in inflammatory lesions, post-acne scarring, and overall skin texture, with minimal risk when appropriate patient selection and operator expertise are ensured. Conclusions: Laser therapy can substantially enhance outcomes in acne and post-acne scar treatment and contribute to improved patient quality of life. Further studies are needed to establish optimal treatment protocols and to compare the effectiveness of specific laser types across different clinical forms of acne.
- Open Access
- 11 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69081
Lithium Through Time: Past Insights, Present Applications and Future Prospects
Introduction and Purpose:Lithium is a cornerstone of psychopharmacology, with expanding roles beyond psychiatry. This narrative review covers its historical evolution, current applications, and emerging uses in psychiatry, neurology, and general medicine—focusing on bipolar disorder, suicide prevention, neurodegeneration, infections, and pregnancy. The aim is to synthesize mechanistic and clinical data showing how lithium’s actions (GSK-3 inhibition, neurotrophic support, anti-inflammatory effects) enable precise, safe prescribing. Materials and Methods:This narrative synthesis draws from recent systematic reviews, meta-analyses, and key studies on lithium’s efficacy, mechanisms, and novel indications (past decade). PubMed, psychiatry/neurology journals, and public health reports were searched using terms like "lithium bipolar," "lithium suicide," "lithium neurodegeneration," prioritizing robust, clinically relevant sources. Results:Lithium is the gold-standard mood stabilizer (50–67% response rates, ~5-fold suicide risk reduction). Trace lithium in water links to lower suicide/dementia rates. Early data support neuroprotection in MCI/Alzheimer’s, plus roles in cluster headache, infections, and perinatal mood—offset by renal/thyroid/cardiac risks needing monitoring. Conclusions:Lithium excels in bipolar disorder and suicide prevention, with neuroprotective, anti-inflammatory potential. Future focus: low-dose regimens, precision monitoring, digital tools.
- 11 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69081
Open AccessLithium Through Time: Past Insights, Present Applications and Future Prospects
Introduction and Purpose:Lithium is a cornerstone of psychopharmacology, with expanding roles beyond psychiatry. This narrative review covers its historical evolution, current applications, and emerging uses in psychiatry, neurology, and general medicine—focusing on bipolar disorder, suicide prevention, neurodegeneration, infections, and pregnancy. The aim is to synthesize mechanistic and clinical data showing how lithium’s actions (GSK-3 inhibition, neurotrophic support, anti-inflammatory effects) enable precise, safe prescribing. Materials and Methods:This narrative synthesis draws from recent systematic reviews, meta-analyses, and key studies on lithium’s efficacy, mechanisms, and novel indications (past decade). PubMed, psychiatry/neurology journals, and public health reports were searched using terms like "lithium bipolar," "lithium suicide," "lithium neurodegeneration," prioritizing robust, clinically relevant sources. Results:Lithium is the gold-standard mood stabilizer (50–67% response rates, ~5-fold suicide risk reduction). Trace lithium in water links to lower suicide/dementia rates. Early data support neuroprotection in MCI/Alzheimer’s, plus roles in cluster headache, infections, and perinatal mood—offset by renal/thyroid/cardiac risks needing monitoring. Conclusions:Lithium excels in bipolar disorder and suicide prevention, with neuroprotective, anti-inflammatory potential. Future focus: low-dose regimens, precision monitoring, digital tools.
- Open Access
- 5 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69004
The Safety and Outcomes of Keratopigmentation as a Cosmetic Eye Color Change Procedure
We review the articles discussing the rationale for performing keratopigmentation (KTP) for purely aesthetic purposes and the safety considerations associated with this method. Originally developed for therapeutic purposes, such as iris defects and corneal opacities, KTP has recently gained popularity as a permanent cosmetic method for changing eye color. Advances in femtosecond-assisted techniques and the use of micronized mineral pigments have enhanced the precision of the procedure and its biocompatibility, contributing to high patient satisfaction rates. Published data, mainly in the form of case reports and small case series, suggest that cosmetic KTP is generally well tolerated. The most commonly reported adverse effects are mild and reversible. Functional parameters typically remain stable, although reductions in contrast sensitivity and mild endothelial cell loss have been reported. Corrective procedures are often necessary, and repeated interventions may increase the risk of complications. Given the limited long-term evidence and the ethical considerations of performing irreversible surgery on healthy eyes, cosmetic KTP should be approached with caution, ensuring thorough patient counseling and careful candidate selection.
- 5 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69004
Open AccessThe Safety and Outcomes of Keratopigmentation as a Cosmetic Eye Color Change Procedure
We review the articles discussing the rationale for performing keratopigmentation (KTP) for purely aesthetic purposes and the safety considerations associated with this method. Originally developed for therapeutic purposes, such as iris defects and corneal opacities, KTP has recently gained popularity as a permanent cosmetic method for changing eye color. Advances in femtosecond-assisted techniques and the use of micronized mineral pigments have enhanced the precision of the procedure and its biocompatibility, contributing to high patient satisfaction rates. Published data, mainly in the form of case reports and small case series, suggest that cosmetic KTP is generally well tolerated. The most commonly reported adverse effects are mild and reversible. Functional parameters typically remain stable, although reductions in contrast sensitivity and mild endothelial cell loss have been reported. Corrective procedures are often necessary, and repeated interventions may increase the risk of complications. Given the limited long-term evidence and the ethical considerations of performing irreversible surgery on healthy eyes, cosmetic KTP should be approached with caution, ensuring thorough patient counseling and careful candidate selection.